TY - JOUR
T1 - Living donor liver transplantation in a patient with giant hepatic hemangioma complicated by Kasabach-Merritt syndrome
T2 - Report of a case
AU - Meguro, Makoto
AU - Soejima, Yuji
AU - Taketomi, Akinobu
AU - Ikegami, Toru
AU - Yamashita, Yo Ichi
AU - Harada, Noboru
AU - Itoh, Shinji
AU - Hirata, Koichi
AU - Maehara, Yoshihiko
PY - 2008/5
Y1 - 2008/5
N2 - We herein present a case of unresectable giant hepatic hemangiomas with Kasabach-Merritt syndrome which was successfully treated by living donor liver transplantation using a left lobe graft. The patient was a 45-year-old woman who complained of abdominal distension. Two sessions of transarterial embolization were performed, but failed to reduce the size of the tumor. The hepatic tumors were thus judged untreatable and the only option for a cure was to offer living donor liver transplantation, because of the tumor size, its location, and the association with Kasabach-Merritt syndrome. A left lobe graft with the middle hepatic vein donated by her 47-year-old brother was transplanted under venovenous bypass. The postoperative course of the recipient was complicated by small-for-size graft syndrome, which developed after episodes of acute cellular rejection on postoperative day 8 and sepsis on day 31. The patient successfully recovered from the complications and was discharged on day 72, and she remains well at 10 months after transplantation. In conclusion, living donor liver transplantation was found to be an effective option for the treatment of a patient with unresectable giant hepatic hemangiomas complicated by Kasabach-Merritt syndrome.
AB - We herein present a case of unresectable giant hepatic hemangiomas with Kasabach-Merritt syndrome which was successfully treated by living donor liver transplantation using a left lobe graft. The patient was a 45-year-old woman who complained of abdominal distension. Two sessions of transarterial embolization were performed, but failed to reduce the size of the tumor. The hepatic tumors were thus judged untreatable and the only option for a cure was to offer living donor liver transplantation, because of the tumor size, its location, and the association with Kasabach-Merritt syndrome. A left lobe graft with the middle hepatic vein donated by her 47-year-old brother was transplanted under venovenous bypass. The postoperative course of the recipient was complicated by small-for-size graft syndrome, which developed after episodes of acute cellular rejection on postoperative day 8 and sepsis on day 31. The patient successfully recovered from the complications and was discharged on day 72, and she remains well at 10 months after transplantation. In conclusion, living donor liver transplantation was found to be an effective option for the treatment of a patient with unresectable giant hepatic hemangiomas complicated by Kasabach-Merritt syndrome.
UR - http://www.scopus.com/inward/record.url?scp=43049124432&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=43049124432&partnerID=8YFLogxK
U2 - 10.1007/s00595-007-3623-4
DO - 10.1007/s00595-007-3623-4
M3 - Article
C2 - 18560973
AN - SCOPUS:43049124432
SN - 0941-1291
VL - 38
SP - 463
EP - 468
JO - Surgery Today
JF - Surgery Today
IS - 5
ER -